Recursion Pharmaceuticals
Recursion Pharmaceuticals, based in Salt Lake City, Utah, is a clinical-stage biotechnology company focused on drug discovery and treatment development through the integration of artificial intelligence, automation, and experimental biology. Founded in 2013, the company employs a sophisticated platform that combines machine learning with high-throughput automated screening to identify potential treatments for diseases that can be modeled at the cellular level. Initially concentrating on drug repurposing for rare diseases, Recursion has expanded its research to address a wider range of conditions, including aging, inflammation, infectious diseases, and immunology. The company's suite of tools includes software for chemical compound design, experimental workflow management, and data analysis, which collectively aim to create a comprehensive understanding of human cellular biology and enhance the efficiency of drug discovery processes.
Vium, Inc. is a biotechnology company focused on transforming preclinical research and enhancing animal welfare through the development of digital biomarkers. Founded in 2013 and headquartered in San Mateo, California, Vium employs advanced technologies such as artificial intelligence, machine learning, and sensor technology to create its Digital Vivarium and Vium Cloud platforms. These platforms enable non-invasive collection of physiological metrics and behaviors, yielding more sensitive and accurate data for researchers. Vium's offerings cater to a diverse clientele, including biotechnology, pharmaceutical, and computational drug discovery firms, as well as academic institutions and therapeutic labs. The company is fully accredited by AAALAC International and has received commendations for its commitment to humane animal research, adhering to the principles of the 3 Rs—Replacement, Reduction, and Refinement. By providing critical insights into disease progression, Vium assists researchers in making informed decisions about which compounds should advance to clinical trials, thereby accelerating the drug discovery and development pipeline.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.